Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2026-04-20 @ 1:48 AM
Study NCT ID:
NCT01662102
Status:
TERMINATED
Last Update Posted:
2021-10-04
First Post:
2012-08-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
Sponsor:
Spectrum Pharmaceuticals, Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SPI-ZEV-12-302
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None